医療機器としてのソフトウェアの世界市場

医療機器としてのソフトウェアの世界市場は2030年までに5,370万米ドルに達する見込み

2024年に2,220万米ドルと推定される医療機器としてのソフトウェアの世界市場は、2024年から2030年にかけてCAGR 15.9%で成長し、2030年には5,370万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるクラウド導入は、CAGR 14.1％を記録し、分析期間終了時には3,200万米ドルに達すると予測されます。オンプレミスデプロイメントセグメントの成長率は、分析期間中CAGR 18.8%と推定されます。

米国市場は600万米ドルと推定、中国はCAGR 20.7%で成長予測

米国の医療機器としてのソフトウェア市場は、2024年に600万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを20.7%として、2030年までに1,160万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.9％と14.1％と予測されています。欧州では、ドイツがCAGR約12.6%で成長すると予測されています。

世界の医療機器としてのソフトウェア市場- 主要動向と促進要因のまとめ

コードだけで治療できるのか？医療機器としてのソフトウェアがヘルスケアの常識を塗り替える理由

医療機器としてのソフトウェア（SaMD）は、ハードウェアに依存しないソフトウェアプログラムが、診断、治療推奨、疾患モニタリングなどの機能を実行できるようにすることで、ヘルスケアに革命をもたらしています。デバイスに組み込まれた従来のソフトウェアとは異なり、SaMDはモバイルデバイス、クラウドプラットフォーム、またはデスクトップアプリケーション上で自律的に動作し、遠隔患者管理やデータ駆動型の臨床的意思決定を可能にします。スマートフォンのECGアルゴリズムによる不整脈の検出から、糖尿病予測ソフトウェアによるインスリン投与の最適化まで、SaMDは、特に慢性疾患管理、メンタルヘルス、放射線医学、デジタル治療学において、ヘルスケアの提供方法を変革しています。

SaMDが特に破壊的なのは、物理的な製造を必要とせずに臨床機能を大規模に提供できることです。この俊敏性により、迅速な更新、反復的な改善、リアルタイムのデータ分析が可能になり、これらはすべて腫瘍学、神経学、希少疾患などの複雑な疾患の管理に不可欠なものです。さらに、COVID-19の大流行は、遠隔診断やデジタル・トリアージ用のSaMDツールの検証を加速させ、FDAやEMAなどの規制機関が承認のためのファスト・トラック・パスを確立する道を開いた。個別化された、非侵襲的で継続的なモニタリング・ソリューションに対する需要はかつてないほど高まっており、SaMDは進化し続けるケアの要として位置づけられています。

製薬会社から支払者まで、利害関係者がSaMDに結集しているのはなぜか？

クラウド・コンピューティング、人工知能、モバイル・テクノロジーの融合は、臨床と消費者の両方の場面でSaMDを展開するための肥沃な環境を作り出しました。製薬会社は、デジタルバイオマーカーや実データを利用して治療効果を高め、患者の服薬アドヒアランスを監視することで、SaMDを医薬品開発や市販後調査戦略に組み込む動きが加速しています。また、これらのソフトウェア・ソリューションは、コンパニオン診断、コネクテッド・ドラッグ・デリバリー・デバイス、ウェアラブル・センサーとバンドルされ、包括的なデジタルヘルス・エコシステムを形成しています。支払者や医療提供者にとって、SaMDは早期発見、リスク層別化、介入のためのツールを提供し、入院率の低下やコスト効率の改善を実現します。

規制機関は、イノベーションを阻害することなく患者の安全性を確保する枠組みを確立することで対応しています。FDAのデジタルヘルス・ソフトウェア事前認証プログラム、EUの医療機器規制（MDR）、日本の医薬品医療機器総合機構（PMDA）は、SaMDに合わせた合理的な経路を導入しています。これらの枠組みは、市販後調査、ユーザー中心の設計、実世界での性能検証を重視しています。SaMDはハードウェアから独立して動作するため、地域間で迅速に拡張でき、リソースに制約のあるヘルスケア環境では特に効果的です。バリューベースのケアモデルが世界的に拡大する中、SaMDはプロアクティブで個別化されたヘルスケアの中核的存在となる準備が整っています。

AI、機械学習、実世界データはどのようにSaMDの進化を後押ししているのか？

人工知能と機械学習は、SaMDイノベーションの核心です。これらの技術により、ソフトウェアは膨大なデータセットを分析し、パターンを特定し、高い精度で予測評価を行うことができます。放射線学では、AIを搭載したSaMDは、画像スキャンから腫瘍や骨折などの異常を、人間の専門医に匹敵するかそれ以上の精度で検出することができます。心臓病学では、MLアルゴリズムがECG信号から不整脈や心不全の指標を評価します。行動健康分野では、SaMDソリューションは、会話パターン、表情、デジタル対話データを通じて、不安や抑うつの初期兆候を検出するよう訓練されています。これらの機能は診断精度を高めるだけでなく、より早く、よりパーソナライズされた介入を可能にしています。

実世界データ（RWD）と実世界エビデンス（RWE）は、SaMDの価値提案をさらに推進しています。ソフトウェア・プラットフォームがウェアラブル、電子カルテ、患者報告アウトカムからのデータを統合するにつれて、継続的な学習とリアルタイムのリスク評価のための強力なツールとなります。開発者はクラウドインフラストラクチャと連携学習モデルを活用し、データのプライバシーを確保しながら、多様な集団におけるアルゴリズムのパフォーマンスを向上させています。このようなフィードバックループにより、規制当局は適応性のあるアルゴリズム（新たなエビデンスに基づいて承認後に進化するSaMD製品）を承認することができます。サイバーセキュリティ、HIPAAコンプライアンス、ユーザー認証システムを統合することで、これらのソリューションの安全性と信頼性を確保しています。

医療機器としてのソフトウェアの急成長の要因は？

医療機器としてのソフトウェア市場の成長は、デジタルヘルス業界全体のいくつかの相乗的な力によってもたらされています。その中でも特に、慢性疾患や生活習慣病におけるリモートケアや自己管理ツールに対する需要の高まりが挙げられます。患者が自分の健康をモニターするためにモバイルアプリや接続プラットフォームへの依存を強めている中、SaMDは臨床現場と在宅ケアのギャップを埋めつつあります。さらに、新興市場におけるスマートフォンとクラウドインフラの普及により、SaMDへのアクセスが民主化され、十分なサービスを受けていない人々もAI主導のヘルスケアソリューションの恩恵を受けられるようになっています。

製薬企業や医療技術企業は、SaMDを自社製品の治療効果を拡大し、市場投入後の知見を収集する手段として捉え、市場投入戦略に急速に取り入れています。一方、病院や支払者は、SaMDをトリアージ自動化、患者エンゲージメント、早期発見のために活用し、救急部門の負担を軽減し、ケア連携を改善しています。最後に、ベンチャーキャピタルやプライベートエクイティによるSaMD新興企業への投資は過去最高水準にあり、市場の信頼が厚いことを示しています。ヘルスケアシステムが個別化、データ中心、予防ケアモデルへと進化する中、SaMDは世界なヘルスケア提供において、臨床ツールと戦略的差別化要因の両方の役割を果たす立場にあります。

セグメント

展開（クラウド、オンプレミス）、用途（スクリーニング＆診断、モニタリング＆アラート、慢性疾患管理、デジタル治療、その他用途）、最終用途（病院＆クリニック、在宅医療、その他最終用途）

調査対象企業の例（注目の43社）

• AliveCor
• Apple Inc.
• Arterys Inc.
• Biofourmis
• Brainlab
• Cerner Corporation
• Digital Diagnostics Inc.
• GE Healthcare
• Google Health
• Health Catalyst
• IBM Watson Health
• iSchemaView Inc.
• Medtronic plc
• MindMaze
• Microsoft Health
• Philips Healthcare
• Qlarity Imaging LLC
• Samsung Health
• Siemens Healthineers
• Viz.ai

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Software as a Medical Device Market to Reach US$53.7 Million by 2030

The global market for Software as a Medical Device estimated at US$22.2 Million in the year 2024, is expected to reach US$53.7 Million by 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$32.0 Million by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 18.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.0 Million While China is Forecast to Grow at 20.7% CAGR

The Software as a Medical Device market in the U.S. is estimated at US$6.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.6 Million by the year 2030 trailing a CAGR of 20.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Software as a Medical Device Market - Key Trends & Drivers Summarized

Can Code Alone Cure? Why Software as a Medical Device Is Rewriting Healthcare Norms

Software as a Medical Device (SaMD) is revolutionizing healthcare by allowing software programs-independent of any hardware-to perform functions such as diagnosis, treatment recommendation, or disease monitoring. Unlike traditional software embedded within devices, SaMD operates autonomously on mobile devices, cloud platforms, or desktop applications, enabling remote patient management and data-driven clinical decision-making. From detecting cardiac arrhythmias via smartphone ECG algorithms to optimizing insulin dosing through predictive diabetes software, SaMD is transforming how healthcare is delivered, particularly in chronic disease management, mental health, radiology, and digital therapeutics.

What makes SaMD particularly disruptive is its ability to deliver clinical functionality at scale without the need for physical manufacturing. This agility allows rapid updates, iterative improvements, and real-time data analysis-all essential in managing complex conditions like oncology, neurology, and rare diseases. Additionally, the COVID-19 pandemic accelerated the validation of SaMD tools for remote diagnostics and digital triage, paving the way for regulatory agencies like the FDA and EMA to establish fast-track pathways for their approval. The demand for personalized, non-invasive, and continuous monitoring solutions has never been higher, positioning SaMD as a linchpin in the evolving continuum of care.

Why Are Stakeholders from Pharma to Payers Rallying Behind SaMD?

The convergence of cloud computing, artificial intelligence, and mobile technologies has created a fertile environment for SaMD deployment across both clinical and consumer settings. Pharmaceutical companies are increasingly integrating SaMD into their drug development and post-marketing surveillance strategies, using digital biomarkers and real-world data to enhance therapeutic efficacy and monitor patient adherence. These software solutions are also being bundled with companion diagnostics, connected drug delivery devices, and wearable sensors to form comprehensive digital health ecosystems. For payers and providers, SaMD offers tools for early detection, risk stratification, and intervention that can reduce hospitalization rates and improve cost efficiency.

Regulatory bodies have responded by establishing frameworks that ensure patient safety without stifling innovation. The FDA’s Digital Health Software Precertification Program, the EU Medical Device Regulation (MDR), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) have introduced streamlined pathways tailored for SaMD. These frameworks emphasize post-market surveillance, user-centric design, and real-world performance validation. SaMD’s ability to operate independently of hardware allows it to scale rapidly across geographies, making it especially effective in resource-constrained healthcare settings. As value-based care models expand globally, SaMD is poised to become a core enabler of proactive, personalized healthcare.

How Are AI, Machine Learning, and Real-World Data Powering SaMD Evolution?

Artificial intelligence and machine learning are at the heart of SaMD innovation. These technologies allow software to analyze vast datasets, identify patterns, and make predictive assessments with high precision. In radiology, AI-powered SaMD can detect abnormalities such as tumors or fractures from imaging scans with accuracy comparable to or exceeding human specialists. In cardiology, ML algorithms assess ECG signals for arrhythmias or heart failure indicators. In behavioral health, SaMD solutions are being trained to detect early signs of anxiety or depression through speech patterns, facial expressions, and digital interaction data. These capabilities are not just enhancing diagnostic accuracy but enabling earlier and more personalized interventions.

Real-world data (RWD) and real-world evidence (RWE) are further propelling the value proposition of SaMD. As software platforms integrate data from wearables, electronic health records, and patient-reported outcomes, they become powerful tools for continuous learning and real-time risk assessment. Developers are leveraging cloud infrastructure and federated learning models to ensure data privacy while improving algorithmic performance across diverse populations. This feedback loop is enabling regulatory agencies to approve adaptive algorithms-SaMD products that evolve post-approval based on new evidence. The integration of cybersecurity, HIPAA compliance, and user authentication systems ensures that these solutions remain secure and trustworthy.

What’s Fueling the Exponential Rise of Software as a Medical Device?

The growth in the software as a medical device market is driven by several synergistic forces across the digital health landscape. Chief among them is the escalating demand for remote care and self-management tools, especially in chronic and lifestyle-driven diseases. With patients increasingly relying on mobile apps and connected platforms to monitor their health, SaMD is bridging the gap between clinical settings and home-based care. Moreover, the proliferation of smartphones and cloud infrastructure in emerging markets is democratizing access to SaMD, allowing underserved populations to benefit from AI-driven healthcare solutions.

Pharmaceutical and medtech companies are rapidly incorporating SaMD into their go-to-market strategies, viewing it as a means to extend the therapeutic impact of their products and gather post-market insights. Meanwhile, hospitals and payers are leveraging SaMD for triage automation, patient engagement, and early detection to reduce the burden on emergency departments and improve care coordination. Finally, venture capital and private equity investment in SaMD startups is at an all-time high, signaling strong market confidence. As healthcare systems evolve toward personalized, data-centric, and preventive care models, SaMD is positioned to serve as both a clinical tool and a strategic differentiator in global healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Software as a Medical Device market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics, Other Applications); End-Use (Hospitals & Clinics, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• AliveCor
• Apple Inc.
• Arterys Inc.
• Biofourmis
• Brainlab
• Cerner Corporation
• Digital Diagnostics Inc.
• GE Healthcare
• Google Health
• Health Catalyst
• IBM Watson Health
• iSchemaView Inc.
• Medtronic plc
• MindMaze
• Microsoft Health
• Philips Healthcare
• Qlarity Imaging LLC
• Samsung Health
• Siemens Healthineers
• Viz.ai

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Software as a Medical Device - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Regulatory Recognition of Software-Based Therapeutics Drives Market Legitimacy and Growth
  • Accelerated Adoption of Digital Health and Remote Monitoring Expands Application Scope
  • Increased Investment in AI-Powered Diagnostics and Predictive Algorithms Fuels Innovation
  • Widespread Use in Chronic Disease Management Strengthens Clinical Integration
  • Mobile and Wearable Integration Enhances Real-Time Patient Engagement
  • Regulatory Frameworks Like FDA and EU MDR Enable Clarity and Global Expansion
  • Use in Personalized Medicine and Data-Driven Treatment Planning Expands Precision Health Opportunities
  • Mental Health and Behavioral Therapy Applications Create Rapid Adoption Pathways
  • Reimbursement Inclusion in Select Markets Drives Payor-Supported Growth
  • Cybersecurity and Data Integrity Challenges Highlight the Need for Robust Infrastructure
  • Partnerships Between Tech Startups and Medical Device Firms Accelerate Product Development
  • Rise in Clinical Validation and Real-World Evidence Collection Strengthens Market Trust
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Software as a Medical Device Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Screening & Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Monitoring & Alerting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION